TrialBMC cancer2021

Evaluating the impact of 18F-FDG-PET-CT on risk stratification and treatment adaptation for patients with muscle-invasive bladder cancer (EFFORT-MIBC): a phase II prospective trial.

Flor Verghote et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.